Skip to content
Search

Latest Stories

'53 per cent of those with skin disease feel judged'

A new survey by the British Skin Foundation has revealed that more than half of those with a skin disease feel judged by others.

Additionally, a significant number of people with skin conditions say that it affects their mental health, everyday life and often leaves them feeling embarrassed.


The report said four in five agree that their appearance is important to their general well-being. One in five are unhappy with their skin and appearance in general, with almost all the people surveyed saying they would welcome more research into skin disease.

Matthew Patey, chief executive officer at the British Skin Foundation, says: “It’s clear from the results of our latest survey that skin and appearance play a huge part in our mental health and happiness. Whilst the skin is the body’s largest organ, most people underestimate its importance, dismissing skin issues as simply cosmetic.

"They wouldn’t downplay disease concerning other organs in the body so easily. At the British Skin Foundation, we are working to find cures and treatments for all types of skin disease, including skin cancer. Our survey proves that the public are keen for more research into skin problems, which means we need your support today.”

Appearance skin problems survey

Professor Andrew Thompson, consultant clinical psychologist and British Skin Foundation spokesperson, says: “We know from a multitude of studies conducted by myself and other researchers working in this area, that skin disease is associated with higher risk of experiencing psychological distress. Whilst there may be both complicated physiological and psychosocial reasons why skin conditions are linked to feelings of anxiety and depression, the good news is that psychological treatment can help and consequently it’s important to seek help as soon as symptoms of depression or anxiety are noticed.”

Dr Anjali Mahto, consultant dermatologist and British Skin Foundation spokesperson agrees: “Sadly, I don't find these statistics a shock or surprise as this data mirrors very much what many of us see in clinic. We can no longer ignore the growing links between the skin and mind; skin conditions are not simply cosmetic or beauty issues and those who are suffering need to be taken seriously. No one should have to feel alone or suffer in silence. Please consider seeking help from your GP or dermatologist if your skin is impacting your ability to live your life on a daily basis.”

The British Skin Foundation has been funding skin research for 25 years to help find cures and treatments for a wide range of conditions. Increasingly, the psychological aspects of skin disease are rightly recognised for being just as important as the physical manifestations.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less